Phage display technology: clinical applications and recent innovations

HME Azzazy, WE Highsmith Jr - Clinical biochemistry, 2002 - Elsevier
Phage display is a molecular diversity technology that allows the presentation of large
peptide and protein libraries on the surface of filamentous phage. Phage display libraries …

[PDF][PDF] CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy

B Falini, S Pileri, G Pizzolo, H Durkop, L Flenghi… - Blood, 1995 - researchgate.net
S INCE THE INITIAL description of the Ki-l monoclonal antibody (MoAb) in 1982,'there has
been an overwhelming flood of information concerning the Hodgkm's disease@)-associated …

Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity

L Tian, B Xu, Y Chen, Z Li, J Wang, J Zhang, R Ma… - Nature cancer, 2022 - nature.com
Chemokines such as CC motif ligand 5 (CCL5) regulate immune cell trafficking in the tumor
microenvironment (TME) and govern tumor development, making them promising targets for …

Regulatory CD4+CD25+ T Cells in Tumors from Patients with Early-Stage Non-Small Cell Lung Cancer and Late-Stage Ovarian Cancer

EY Woo, CS Chu, TJ Goletz, K Schlienger, H Yeh… - Cancer research, 2001 - AACR
Immunosuppression may contribute to the progression of cancer. In this study we assessed
the structural and functional status of T cells from tumor specimens obtained from patients …

Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product

HM Finney, ADG Lawson, CR Bebbington… - The Journal of …, 1998 - journals.aai.org
Single chain Fv chimeric receptors, or T-bodies, are described with intracellular sequences
comprising the costimulatory signaling domain of CD28 in series with the ζ-chain from the …

A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity.

M Mack, G Riethmüller, P Kufer - Proceedings of the …, 1995 - National Acad Sciences
Construction of a bispecific single-chain antibody derivative is described that consists of two
different single-chain Fv fragments joined through a Gly-Ser linker. One specificity of the two …

Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies

C Klein, C Sustmann, M Thomas, K Stubenrauch… - MAbs, 2012 - Taylor & Francis
The development of bispecific antibodies has attracted substantial interest, and many
different formats have been described. Those specifically containing an Fc part are mostly …

A revival of bispecific antibodies

P Kufer, R Lutterbüse, PA Baeuerle - Trends in biotechnology, 2004 - cell.com
Bispecific antibodies usually do not occur in nature but are constructed by recombinant DNA
or cell-fusion technologies. Most are designed to recruit cytotoxic effector cells of the …

A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies

D Skokos, JC Waite, L Haber, A Crawford… - Science translational …, 2020 - science.org
T cell activation is initiated upon binding of the T cell receptor (TCR)/CD3 complex to peptide–
major histocompatibility complexes (“signal 1”); activation is enhanced by engagement of a …

Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing

R Zeidler, G Reisbach, B Wollenberg… - The Journal of …, 1999 - journals.aai.org
Bispecific Abs (bsAb) are promising immunological tools for the elimination of tumor cells in
minimal residual disease situations. In principle, they target an Ag on tumor cells and recruit …